[Primary prevention of diabetes mellitus by pharmacological intervention].
Noda
Mitsuhiko
M
Institute for Diabetes Care and Research, Asahi Life Foundation.
D020909:Acarbose / Q000008:administration & dosage; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D002839:Chromans / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D000960:Hypolipidemic Agents / Q000008:administration & dosage; D007783:Lactones / Q000008:administration & dosage; D008687:Metformin / Q000008:administration & dosage; D000077403:Orlistat; D017035:Pravastatin / Q000008:administration & dosage; D011322:Primary Prevention / Q000379:methods*; D017257:Ramipril / Q000008:administration & dosage; D013844:Thiazoles / Q000008:administration & dosage; D045162:Thiazolidinediones; D000077288:Troglitazone
D000806:Angiotensin-Converting Enzyme Inhibitors; D002839:Chromans; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D007783:Lactones; D013844:Thiazoles; D045162:Thiazolidinediones; D008687:Metformin; D000077403:Orlistat; D000077288:Troglitazone; D017035:Pravastatin; D017257:Ramipril; D020909:Acarbose